Personalis (PSNL) had its price target lowered by Morgan Stanley from $11.00 to $10.00. They now have an "equal weight" rating on the stock.
Personalis (PSNL) had its price target raised by Needham & Company LLC from $10.00 to $12.00. They now have a "buy" rating on the stock.
Personalis Inc (PSNL) Q4 2025 Earnings Call Highlights: Robust Clinical Growth Amidst Revenue ... [Yahoo! Finance]
Personalis outlines 170% clinical test volume growth target for 2026 as reimbursement and MRD strategy accelerate [Seeking Alpha]
Personalis, Inc. (PSNL) Q4 2025 Earnings Call Transcript [Seeking Alpha]